Back to Search
Start Over
Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey
- Source :
- European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 26(11)
- Publication Year :
- 2007
-
Abstract
- Piperacillin-Tazobactam (Pip-Taz) is an evidence-based empirical treatment of febrile neutropenia in adolescents and adults. No data are available in pediatric cancer patients
- Subjects :
- Microbiology (medical)
Pediatrics
medicine.medical_specialty
Neutropenia
Penicillanic Acid
Fever of Unknown Origin
Neoplasms
Hypersensitivity
Medicine
Humans
Adverse effect
Antibacterial agent
Retrospective Studies
Piperacillin
business.industry
Infant, Newborn
Infant
Retrospective cohort study
General Medicine
Bacterial Infections
medicine.disease
Rash
Pediatric cancer
Infectious Diseases
Piperacillin, Tazobactam Drug Combination
Treatment Outcome
Withholding Treatment
Piperacillin/tazobactam
medicine.symptom
business
Febrile neutropenia
medicine.drug
Subjects
Details
- ISSN :
- 09349723
- Volume :
- 26
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology
- Accession number :
- edsair.doi.dedup.....893700b2c51157213421e3bebf49118c